PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis

J Neurol Sci. 2019 Apr 15:399:97-100. doi: 10.1016/j.jns.2019.02.023. Epub 2019 Feb 13.

¹ Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan.
² Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan. Electronic address: ikeguchi.ryotaro@twmu.ac.jp.
³ Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan. Electronic address: kobayashi.masaki@twmu.ac.jp.
⁴ Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan. Electronic address: suzuki.miki@twmu.ac.jp.
⁵ Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan. Electronic address: shimizu.yuko@twmu.ac.jp.
⁶ Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan. Electronic address: kitagawa.kazuo@twmu.ac.jp.

No abstract available

Keywords: Myasthenia gravis; Myocarditis; Myopathy; Nivolumab; Programmed cell death protein 1 inhibitor; Thymoma.

Publication types